Healthcare - Biotechnology - NASDAQ - US
$ 0.5683
9.2 %
$ 23.2 M
Market Cap
-0.16
P/E
Price Target
Average
3017.07%
Revenue Forecast
Estimate
196.18%
EBIT
Estimate
20.76%
Net Income
Estimate
53.20%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
BioXcel Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for BTAI of $17.7 , with forecasts ranging from a low of $1 to a high of $73 .
BTAI Lowest Price Target
Wall Street Target
1 USD
75.96%
BTAI Average Price Target
Wall Street Target
17.7 USD
3017.07%
BTAI Highest Price Target
Wall Street Target
73 USD
12745.33%
REVENUE FORECAST
Revenue Forecast Chart BTAI
EBIT FORECAST
EBIT Forecast Chart BTAI
NET INCOME FORECAST
Net Income Chart BTAI